The Ewing’s sarcoma (EWS) oncogene contains an N-terminal transcrip-tion activation domain and a C-terminal RNA-binding domain. Although the EWS activation domain is a potent transactivation domain that is required for the oncogenic activity of several EWS fusion proteins, the nor-mal role of intact EWS is poorly characterized because little is known about its nucleic acid recognition specificity.